Search
164 studies match these filters. Showing 101–125 of 164 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT07654374 | A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) This is randomized, double-blind, placebo-controlled study of the long-term efficacy, safety, and tolerability of multiple doses of aleniglipron in participants living with overweight or obesity and T2DM. Participants will be randomized to aleniglipron or placebo for a total of 76 weeks of treatment. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 74 sites in total · contact listed | Recruiting | Phase 3 | 1,100target | 74 / 1 | 2026 | Sep 11, 2026 | |
| NCT07069673 | Abbott Cephea Mitral Valve Disease Registry The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of cor… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 24 sites in total · contact listed | Recruiting | 1,000target | 24 / 1 | 2025 | Sep 10, 2026 | ||
| NCT03959085 | Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy and immunotherapy (chemo-immunotherapy) for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. Inotuzumab ozogamicin is a monoclonal antibody, which is a type of protei… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 231 sites in total · contact listed | Recruiting | Phase 3 | 5,951target | 231 / 5 | 2019 | Aug 25, 2026 | |
| NCT04566328 | Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell g… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 647 sites in total | Recruiting | Phase 3 | 1,450target | 647 / 2 | 2021 | Aug 19, 2026 | |
| NCT07654361 | Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) Study GSBR-1290-12 is a Phase 3 pivotal, multicenter, global, randomized, placebo-controlled, double-blind study to investigate the long-term efficacy, safety, and tolerability of 3 maintenance doses of aleniglipron once daily (QD) compared with placebo, when used in combination with a reduced-calor… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 71 sites in total · contact listed | Recruiting | Phase 3 | 3,600target | 71 / 1 | 2026 | Aug 10, 2026 | |
| NCT05172973 | ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects who are at high or greater risk with a failing aortic bioprosthetic valve. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 36 sites in total | Recruiting | Not applicable | 200target | 36 / 2 | 2023 | Jul 27, 2026 | |
| NCT06533644 | A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer The primary purpose of this study is to evaluate the safety, tolerability, and efficacy of SYNC-T Therapy SV-102 and to identify the maximum tolerated dose (MTD) and/or selected dose for phase 2b study. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total | Recruiting | Phase 2 | 91target | 23 / 1 | 2025 | Jun 23, 2026 | |
| NCT07190300 | TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) The purpose of the study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 31 sites in total · contact listed | Recruiting | Phase 1 / Phase 2 | 181target | 31 / 14 | 2026 | Jun 23, 2026 | |
| NCT07207408 | Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age This study will evaluate the immunogenicity, safety, and tolerability of rF1V-1018 vaccine ✓ Contact✗ Claimed Nearest site: El Dorado, Kansas, United States — 85 km away · 4 sites in total | Recruiting | Phase 2 | 148target | 4 / 1 | 2025 | Jun 18, 2026 | |
| NCT05491525 | Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 38 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 71target | 38 / 16 | 2022 | Jun 15, 2026 | |
| NCT06628908 | Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 76 sites in total | Recruiting | Phase 3 | 1,100target | 76 / 1 | 2024 | Jun 15, 2026 | |
| NCT06527222 | A Study of Ranolazine in ALS The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 6 sites in total · contact listed | Recruiting | Phase 2 | 72target | 6 / 1 | 2025 | Jun 8, 2026 | |
| NCT07382167 | A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults This is a 26-week, multi-center, randomized, double-blind, placebo-controlled study with a 4-week treatment-free Safety Follow-up period to assess the safety and efficacy of tenapanor (5 mg, 25mg, and 50 mg) in adult patients with Chronic Idiopathic Constipation (CIC) when administered twice daily f… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 109 sites in total · contact listed | Recruiting | Phase 3 | 692target | 109 / 1 | 2026 | Jun 4, 2026 | |
| NCT05675410 | A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard treatment alone in improving survival in patients with stage I and II classical Hodgkin lymphoma. Brentuximab vedotin is… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 415 sites in total · contact listed | Recruiting | Phase 3 | 1,875target | 415 / 3 | 2023 | Sep 18, 2026 | |
| NCT07609108 | Pridopidine Phase 3 Study in Huntington's Disease The goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine. The main questions the study aims to answer are: Does pridopidine slow the overall worsening of HD over… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 66 sites in total · contact listed | Recruiting | Phase 3 | 400target | 66 / 12 | 2026 | Sep 17, 2026 | |
| NCT04181060 | Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signa… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 603 sites in total · contact listed | Recruiting | Phase 3 | 300target | 603 / 1 | 2020 | Sep 10, 2026 | |
| NCT07662213 | A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM and increased cardiovascular risk that is inadequately managed alone or on stable treatment with other background glucose-lowering medication(s). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 209 sites in total | Recruiting | Phase 3 | 1,200target | 209 / 15 | 2026 | Sep 9, 2026 | |
| NCT06510374 | Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC) ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 107 sites in total | Recruiting | Phase 3 | 454target | 107 / 9 | 2024 | Sep 4, 2026 | |
| NCT05913908 | EFS of the DUO System for Tricuspid Regurgitation The study is an early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function of the DUO Transcatheter Tricuspid Coaptation Valve System (DUO System). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 15 sites in total · contact listed | Recruiting | Not applicable | 15target | 15 / 2 | 2024 | Jun 1, 2026 | |
| NCT06693895 | A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age The purpose of this study is to assess how well-tolerated GSK's investigational varicella vaccine (VNS Vaccine) is, in comparison to an already approved varicella vaccine (VV) known as Varivax. The study will be conducted on healthy children aged 12 to 15 months, and who have neither contracted vari… ✓ Contact✗ Claimed Nearest site: El Dorado, Kansas, United States — 85 km away · 46 sites in total | Recruiting | Phase 3 | 750target | 46 / 8 | 2024 | May 29, 2026 | |
| NCT06777368 | REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 71 sites in total · contact listed | Recruiting | 225target | 71 / 1 | 2025 | May 28, 2026 | ||
| NCT03851445 | Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will deter… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 1,229 sites in total | Recruiting | Phase 2 / Phase 3 | 10,000target | 1,229 / 1 | 2019 | May 18, 2026 | |
| NCT06172296 | Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuximab… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 179 sites in total · contact listed | Recruiting | Phase 3 | 478target | 179 / 5 | 2024 | Sep 17, 2026 | |
| NCT03067181 | Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 629 sites in total · contact listed | Recruiting | Phase 3 | 1,780target | 629 / 9 | 2017 | Aug 25, 2026 | |
| NCT06535854 | Prevail Global Study The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 51 sites in total · contact listed | Recruiting | Not applicable | 1,205target | 51 / 1 | 2025 | Apr 24, 2026 |